[1] Chao C P, Kotsenas A L, Broderick D F. Cerebrai amyloid angiopathy: CT and MR imaging findings[J].Radiographics, 2006, 26(5): 1517-1531.

[2] Rovelet-Lecrux A, Hannequin D, Raux,G. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy [J]. Nat Genet, 2006, 38: 24-26.

[3] 张 昱,吴 江,苏 牧. 老年型阿尔茨海默病的病理与影像学对照研究[J]. 中华神经科杂志, 2001, 34(4): 204-206.

[4] De Leon M J, George A E, Stylopoulos L A, et al. Early marker for Alzheimer’s disease: the atrophic hippocampus [J]. Lancet, 1989, II(8664): 672-673.

[5] Jobst K A, Smith A D, Barker C S, et al. Association of atrophy of medial temporal lobe with reduced blood flow in patients with a clinical and pathological diagnosis of Alzheimer’s disease [J]. J Neurol Neurosury Psychiatry, 1992, 55: 190-196.

[6] 陈平有,陈学强,杜恩甫,等. MRI在脑血管淀粉样变脑出血诊断中的应用[J]. 实用放射学杂志, 2011, 27(12):1807-1810.

[7] Masters C L, Simms G, Weinman N A, et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome [J]. Proc Natl Acad Sci USA, 1985, 82(12): 4245-4248.

[8] McCarron M O, Nicoll J A, Love S, et al. Surgical intervention, biopsy and APOE genotype in cerebral amyloid angiopathy 2 related haemorrhage [J]. Br J Neurosurg, 1999, 13: 462-465.

[9] Maat-Schieman M, Roos R, Van Duinen S. Hereditary cerebral hemorrhage with amyloidosis-Dutch type[J]. Neuropathology, 2005, 25(4): 288-297.

[10] Attems J. Sporadic cerebral amyloid angiopathy: pathology,clinical implications, and possible pathomechanisms [J]. Acta Neuropathol(Berl), 2005, 110(4): 345-359.

[11] Rosand J, Muzikansky A, Kumar A, et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy [J]. Ann Neurol, 2005, 58(3): 459-462.

[12] Izumihara A, Suzuki M, Ishihara T. Recurrence and extension of lobar hemorrhage related to cerebral amyloid ngilpathy:multivariate analysis of clinical risk factors[J]. Surg Neurol, 2005, 64(2): 160-164.

[13] Iwata N, Tsubuki S, Takaki Y, et al. Metabolic regulation of brain Aβ by neprilysin[J]. Scienc, 2001, 292: 1550-1552.

[14] Mouri A, Zou L B, Iwata N, et al. Inhibition of neprilysin by thiorphan (i.c.v) causes an accumulation of amyloid and impairment of learning and memory[J]. Behav Br Res, 2006, 168: 83-91.

[15] Iwata N, Takaki Y, Fukami S, et al. Region-specific reduction of A β degrading endopeptidase, neprilysin, in mouse hippocampus upon aging[J]. J Neurosci Res, 2002,70: 493-500.

[16] Nobuhisa I, Tsubuki S. Identification of the major Aβ 1-42-degrading catabolic pathway in brain parenchyma: Su-ppression leads to biochemical and pathological deposition [J]. Natrue Med, 2000, 6: 143-150.

[17] Nobuhisa I, Mizukami H, Sirotani K, et al. Presynaptic localization of neprilysin contributes to efficient clearance of amyloid –β peptide in mouse brain [J]. J Neurosci, 2004, 24(4): 991-998.

[18] 樊东升. 脑淀粉样血管病相关性出血[J]. 国外医学脑血管疾病分册, 2001, 9(4): 234-236.

[19] 许 丹,杨春慧, 王鲁宁, 等. 老年人脑淀粉样血管病的临床及病理研究[J]. 中华内科杂志, 2003, 42(8): 541-543.

[20] 殷小平,张苏明,郑美蓉, 等. 血管淀粉样变相关脑出血的初步研究[J]. 中华医学杂志,2005,85(2):120-121.

[21] Huang J, Guan H, Booze R M, et al. Estrogen regulates neprilysin activity in rat brain [J]. Neurosci Lett, 2004, 367(1): 85-87.

[22] Shirotani K, Tsubuki S, Iwata N, et al. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidlyand drriciently among thiorphan-and phosphoramidon-sensitive endopeptidases[J]. J Biol Chem, 2001, 276(24): 21895-21901.

[23] Marr R A, Rockenstein E, Mukherjee A, et al. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice[J]. J Neurosci, 2003, 23(6): 1992-1996.

[24] Tian J, Shi J, Bailey K, et al. Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer’s disease [J]. Neuropathol Appl Neurobiol, 2004, 30(1): 46-56.

[25] Hauss-Wegrzyniak B, Wenk G L. Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle [J]. Neurosci Lett, 2002, 322(2): 75-78.